Controversies in the temperature management of critically ill patients

被引:9
|
作者
Nakajima, Yasufumi [1 ]
机构
[1] Kansai Med Univ, Dept Anesthesiol & Intens Care, Shinmachi 2-3-1, Hirakata, Osaka 5731191, Japan
基金
日本学术振兴会;
关键词
Therapeutic hypothermia; Fever; Temperature management; Intensive care; HOSPITAL CARDIAC-ARREST; EUROPEAN RESUSCITATION COUNCIL; AMERICAN-HEART-ASSOCIATION; EARLY PEAK TEMPERATURE; CARDIOPULMONARY-RESUSCITATION; BODY-TEMPERATURE; MILD HYPOTHERMIA; THERMOREGULATORY RESPONSES; PREHOSPITAL INDUCTION; CUTANEOUS VASODILATOR;
D O I
10.1007/s00540-016-2200-7
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Although body temperature is a classic primary vital sign, its value has received little attention compared with the others (blood pressure, heart rate, and respiratory rate). This may result from the fact that unlike the other primary vital signs, aging and diseases rarely affect the thermoregulatory system. Despite this, when humans are exposed to various anesthetics and analgesics and acute etiologies of non-infectious and infectious diseases in perioperative and intensive care settings, abnormalities may occur that shift body temperature up and down. A recent upsurge in clinical evidence in the perioperative and critical care field resulted in many clinical trials in temperature management. The results of these clinical trials suggest that aggressive body temperature modifications in comatose survivors after resuscitation from shockable rhythm, and permissive fever in critically ill patients, are carried out in critical care settings to improve patient outcomes; however, its efficacy remains to be elucidated. A recent, large multicenter randomized controlled trial demonstrated contradictory results, which may disrupt the trends in clinical practice. Thus, updated information concerning thermoregulatory interventions is essential for anesthesiologists and intensivists. Here, recent controversies in therapeutic hypothermia and fever management are summarized, and their relevance to the physiology of human thermoregulation is discussed.
引用
收藏
页码:873 / 883
页数:11
相关论文
共 50 条
  • [21] Urine biochemistry assessment in critically ill patients: controversies and future perspectives
    Alexandre Toledo Maciel
    Daniel Vitorio
    Journal of Clinical Monitoring and Computing, 2017, 31 : 539 - 546
  • [22] Urine biochemistry assessment in critically ill patients: controversies and future perspectives
    Maciel, Alexandre Toledo
    Vitorio, Daniel
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 2017, 31 (03) : 539 - 546
  • [23] Current controversies around tight glucose control in critically ill patients
    Devos, Philippe
    Preiser, Jean-Charles
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2007, 10 (02): : 206 - 209
  • [24] Controversies related to red blood cell transfusion in critically ill patients
    Prittie, Jennifer E.
    JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2010, 20 (02) : 167 - 176
  • [25] Controversies in nutritional support for critically ill children
    Askegard-Giesmann, Johanna R.
    Kenney, Brian D.
    SEMINARS IN PEDIATRIC SURGERY, 2015, 24 (01) : 20 - 24
  • [26] Focus on cardiovascular management in critically ill patients
    Hjortrup, Peter Buhl
    Sandroni, Claudio
    Aneman, Anders
    INTENSIVE CARE MEDICINE, 2020, 46 (08) : 1607 - 1610
  • [27] Individualized glycemic management for critically ill patients
    Okazaki, Tomoya
    Inoue, Akihiko
    Kuroda, Yasuhiro
    INTENSIVE CARE MEDICINE, 2022, 48 (01) : 126 - 127
  • [28] Unstoppable Glycemic Management in Critically Ill Patients
    Lewis, Patricia
    Fisher, Christine
    Ike, Chiamaka
    Layinka, Tumininu
    Hebert, Cullen
    Manzano, Mary
    Malit, Luz
    Gonzales, Elizabeth
    Desai, Sapana
    CRITICAL CARE NURSE, 2020, 40 (02) : E50 - E51
  • [29] Focus on cardiovascular management in critically ill patients
    Peter Buhl Hjortrup
    Claudio Sandroni
    Anders Aneman
    Intensive Care Medicine, 2020, 46 : 1607 - 1610
  • [30] ANALYSIS OF PAIN MANAGEMENT IN CRITICALLY ILL PATIENTS
    WHIPPLE, JK
    LEWIS, KS
    QUEBBEMAN, EJ
    WOLFF, M
    GOTTLIEB, MS
    MEDICUSBRINGA, M
    HARTNETT, KR
    GRAF, M
    AUSMAN, RK
    PHARMACOTHERAPY, 1995, 15 (05): : 592 - 599